Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Capital One Financial Corp. (COF) vs Quest Diagnostics Inc (DGX) Price & Performance

Capital One Financial Corp.Trade
Quest Diagnostics IncTrade

Price performance (Past 24H)

Key statistics

Capital One Financial Corp. vs Quest Diagnostics Inc — how do they compare? Capital One Financial Corp. trades at $222.85 (market cap $134.45B), while Quest Diagnostics Inc trades at $237.95 (market cap $26.21B). The key difference: Capital One Financial Corp. is far larger — about 5.1× Quest Diagnostics Inc's market cap, and Capital One Financial Corp. pays the higher dividend (1.46%). Which is the better fit depends on your goals.

COFDGX
Market Cap
$134.45B$26.21B
Sector
FinancialsHealth
52-Week High
$257.94$238.50
52-Week Low
$176.10$173.49
Dividend Yield
1.46%1.45%
Enterprise Value
$31.97B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Capital One Financial Corp.

Capital One Financial (COF) trades at $223.09, up 1.88% on the day, with a bullish technical signal from moving averages. The stock shows strong fundamentals with a P/E of 12.07 and P/B of 1.18, while Q2 2026 earnings beat expectations. Recent news highlights the Discover integration progress and a 20-year arena naming rights extension, reinforcing brand commitment.

The outlook is positive with a consensus price target of $251.60, implying 13% upside, supported by 63% analyst buy ratings. Key risks include integration execution of Discover, credit loss provisions, and macroeconomic sensitivity. Revenue growth to $62.0B in 2026 projects a net income margin rebound to 16.96%, offering a compelling value proposition if synergies materialize.

Quest Diagnostics Inc

Quest Diagnostics (DGX) trades at $237.24, down 0.16% on the day, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $3.12 and raising its full-year outlook, driven by robust testing demand. Revenue grew to $11.04B in 2025, with net income of $992M, though margins face pressure from lower-margin deals and rising costs.

The outlook is positive due to raised guidance and AI integration enhancing efficiency, but risks include debt levels and margin compression. Analysts maintain a cautious buy stance with a $249.50 price target, indicating modest upside potential from current levels amid competitive and cost challenges.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Capital One Financial Corp.

Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.

Read more on COF

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Read more on DGX